These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection. Brown EL; Nishiyama Y; Dunkle JW; Aggarwal S; Planque S; Watanabe K; Csencsits-Smith K; Bowden MG; Kaplan SL; Paul S J Biol Chem; 2012 Mar; 287(13):9940-9951. PubMed ID: 22303018 [TBL] [Abstract][Full Text] [Related]
44. Bacterial cell wall-expressed protein A triggers supraclonal B-cell responses upon in vivo infection with Staphylococcus aureus. Palmqvist N; Silverman GJ; Josefsson E; Tarkowski A Microbes Infect; 2005 Dec; 7(15):1501-11. PubMed ID: 16039897 [TBL] [Abstract][Full Text] [Related]
45. Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis. Bunikowski R; Mielke M; Skarabis H; Herz U; Bergmann RL; Wahn U; Renz H J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):119-24. PubMed ID: 9893195 [TBL] [Abstract][Full Text] [Related]
46. Reduced Immunoglobulin (Ig) G Response to Staphylococcus aureus in STAT3 Hyper-IgE Syndrome. Stentzel S; Hagl B; Abel F; Kahl BC; Rack-Hoch A; Bröker BM; Renner ED Clin Infect Dis; 2017 May; 64(9):1279-1282. PubMed ID: 28203787 [TBL] [Abstract][Full Text] [Related]
47. Glycan-specific IgM is critical for human immunity to Staphylococcus aureus. Hendriks A; Kerkman PF; Varkila MRJ; Haitsma Mulier JLG; Ali S; Ten Doesschate T; van der Vaart TW; de Haas CJC; Aerts PC; Cremer OL; Bonten MJM; Nizet V; Liu GY; Codée JDC; Rooijakkers SHM; van Strijp JAG; van Sorge NM Cell Rep Med; 2024 Sep; 5(9):101734. PubMed ID: 39293400 [TBL] [Abstract][Full Text] [Related]
50. Intranasal immunization of mutant toxic shock syndrome toxin 1 elicits systemic and mucosal immune response against Staphylococcus aureus infection. Narita K; Hu DL; Tsuji T; Nakane A FEMS Immunol Med Microbiol; 2008 Apr; 52(3):389-96. PubMed ID: 18312579 [TBL] [Abstract][Full Text] [Related]
51. Prevalence of toxic shock syndrome toxin 1 (TSST-1)-producing strains of Staphylococcus aureus and antibody to TSST-1 among healthy Japanese women. Parsonnet J; Goering RV; Hansmann MA; Jones MB; Ohtagaki K; Davis CC; Totsuka K J Clin Microbiol; 2008 Aug; 46(8):2731-8. PubMed ID: 18550735 [TBL] [Abstract][Full Text] [Related]
52. Nasal carriers are more likely to acquire exogenous Staphylococcus aureus strains than non-carriers. Ghasemzadeh-Moghaddam H; Neela V; van Wamel W; Hamat RA; Shamsudin MN; Hussin NS; Aziz MN; Haspani MS; Johar A; Thevarajah S; Vos M; van Belkum A Clin Microbiol Infect; 2015 Nov; 21(11):998.e1-7. PubMed ID: 26183299 [TBL] [Abstract][Full Text] [Related]
53. Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease. Tkaczyk C; Hamilton MM; Sadowska A; Shi Y; Chang CS; Chowdhury P; Buonapane R; Xiao X; Warrener P; Mediavilla J; Kreiswirth B; Suzich J; Stover CK; Sellman BR mBio; 2016 Jun; 7(3):. PubMed ID: 27353753 [TBL] [Abstract][Full Text] [Related]
54. Protection against Staphylococcus aureus Colonization and Infection by B- and T-Cell-Mediated Mechanisms. Zhang F; Ledue O; Jun M; Goulart C; Malley R; Lu YJ mBio; 2018 Oct; 9(5):. PubMed ID: 30327437 [No Abstract] [Full Text] [Related]
55. Mechanism of action and in vivo efficacy of a human-derived antibody against Staphylococcus aureus α-hemolysin. Foletti D; Strop P; Shaughnessy L; Hasa-Moreno A; Casas MG; Russell M; Bee C; Wu S; Pham A; Zeng Z; Pons J; Rajpal A; Shelton D J Mol Biol; 2013 May; 425(10):1641-54. PubMed ID: 23416200 [TBL] [Abstract][Full Text] [Related]
56. Characterization of peripheral blood mononuclear cells gene expression profiles of pediatric Staphylococcus aureus persistent and non-carriers using a targeted assay. Israelsson E; Chaussabel D; Fischer RSB; Moore HC; Robinson DA; Dunkle JW; Essigmann HT; Record S; Brown EL Microbes Infect; 2020; 22(10):540-549. PubMed ID: 32758644 [TBL] [Abstract][Full Text] [Related]
57. Staphylococcus aureus nasal carriage as a marker for subsequent staphylococcal infections in intensive care unit patients. Corbella X; Domínguez MA; Pujol M; Ayats J; Sendra M; Pallares R; Ariza J; Gudiol F Eur J Clin Microbiol Infect Dis; 1997 May; 16(5):351-7. PubMed ID: 9228474 [TBL] [Abstract][Full Text] [Related]
58. Immunization of young heifers with staphylococcal immune evasion proteins before natural exposure to Staphylococcus aureus induces a humoral immune response in serum and milk. Benedictus L; Ravesloot L; Poppe K; Daemen I; Boerhout E; van Strijp J; Broere F; Rutten V; Koets A; Eisenberg S BMC Vet Res; 2019 Jan; 15(1):15. PubMed ID: 30616609 [TBL] [Abstract][Full Text] [Related]
59. Enzyme-linked immunosorbent assay for the detection of antibodies to exocellular proteins of Staphylococcus aureus in bone infection. Lambert PA; Krikler SJ; Patel R; Parvathan S FEMS Microbiol Lett; 1992 Dec; 100(1-3):67-70. PubMed ID: 1478482 [TBL] [Abstract][Full Text] [Related]
60. Staphylococcus aureus infection triggers production of neutralizing, V8 protease-specific antibodies. Calander AM; Dubin G; Potempa J; Tarkowski A FEMS Immunol Med Microbiol; 2008 Mar; 52(2):267-72. PubMed ID: 18205806 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]